G. Ruiz-Argüelles

Serologic follow-up in patients with multiple myeloma without repeated bone marrow studies: a single-institution experience.

INTRODUCTION Assessment of measurable residual disease (MRD) in multiple myeloma (MM) often relies on repeated bone marrow evaluations, which are invasive, costly, and not universally accessible. Alternative monitoring approaches based on routinely available laboratory tests may provide clinically relevant prognostic i...